Cambridge Investment Research Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $263K | Buy |
1,089
+56
| +5% | +$13.5K | ﹤0.01% | 3088 |
|
|
2025
Q1 | $252K | Buy |
1,033
+209
| +25% | +$51K | ﹤0.01% | 3014 |
|
|
2024
Q4 | $271K | Buy |
+824
| New | +$271K | ﹤0.01% | 2915 |
|
|
2024
Q2 | – | Sell |
-4,798
| Closed | -$1.66M | – | 3324 |
|
|
2024
Q1 | $1.66M | Buy |
4,798
+4,139
| +628% | +$1.43M | 0.01% | 1389 |
|
|
2023
Q4 | $213K | Sell |
659
-33
| -5% | -$10.7K | ﹤0.01% | 2849 |
|
|
2023
Q3 | $248K | Sell |
692
-40
| -5% | -$14.3K | ﹤0.01% | 2650 |
|
|
2023
Q2 | $278K | Sell |
732
-167
| -19% | -$63.4K | ﹤0.01% | 2596 |
|
|
2023
Q1 | $431K | Sell |
899
-50
| -5% | -$24K | ﹤0.01% | 2193 |
|
|
2022
Q4 | $399K | Buy |
949
+141
| +17% | +$59.3K | ﹤0.01% | 2200 |
|
|
2022
Q3 | $337K | Sell |
808
-140
| -15% | -$58.4K | ﹤0.01% | 2270 |
|
|
2022
Q2 | $469K | Sell |
948
-95
| -9% | -$47K | ﹤0.01% | 2009 |
|
|
2022
Q1 | $587K | Sell |
1,043
-259
| -20% | -$146K | ﹤0.01% | 1974 |
|
|
2021
Q4 | $984K | Sell |
1,302
-336
| -21% | -$254K | ﹤0.01% | 1590 |
|
|
2021
Q3 | $1.22M | Buy |
1,638
+201
| +14% | +$150K | 0.01% | 1382 |
|
|
2021
Q2 | $926K | Buy |
1,437
+337
| +31% | +$217K | ﹤0.01% | 1582 |
|
|
2021
Q1 | $628K | Buy |
1,100
+350
| +47% | +$200K | ﹤0.01% | 1726 |
|
|
2020
Q4 | $437K | Buy |
750
+273
| +57% | +$159K | ﹤0.01% | 1859 |
|
|
2020
Q3 | $246K | Buy |
+477
| New | +$246K | ﹤0.01% | 2084 |
|